Signal Pharmaceuticals, LLC
Records under this name other than the patents Signal Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 90 patents it holds.
Back to Signal Pharmaceuticals, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,723,340 | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,245,258 | Treatment of a Hematologic Malignancy with 2-(4-Chlorophenyl)-N-((2-(2,6-Dioxopiperidin-3-YL)-1-Oxoisoindolin-5-YL)METHYL)-2,2-Difluoroacetamide Formerly held In force · High confidence | In force | High confidence | |
| US 10,751,414 | Methods of Treating Psoriasis Using PD-1 Binding Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 10,357,489 | Antiproliferative Compounds and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,675,281 | Antiproliferative Compounds and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,185,543 | Antiproliferative Compounds and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,029,738 | Antiproliferative Compounds and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,401,336 | Bcma-Binding Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,358,952 | Substituted 4-Aminoisoindoline-1,3-Dione Compounds, Compositions Thereof, and Methods of Treatment Therewith Formerly held In force · High confidence | In force | High confidence | |
| US 10,969,381 | Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-Dioxopiperidin-3-YL)-1-Oxoisoindolin-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-Fluorobenzonitrile Formerly held In force · High confidence | In force | High confidence |